Senti Biosciences Long Term Debt

Senti Biosciences (SNTI) currently reports a long-term debt of $13M as of June 2026. That compares with $53M in the prior-year period — down 75.8% year over year. Use the charts on this page to explore Senti Biosciences's long-term debt history and peer comparisons.

Senti Biosciences's long-term debt decreased from $53M to $13M — a 75.8% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Senti Biosciences reported $13M in long-term debt as of June 2026. That compares with $53M in the prior-year period — down 75.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $13M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Senti Biosciences, and consider following SNTI for alerts when major investors trade the stock.